TREE NEWS update: Moderna reported third-quarter earnings per share of $0.38, beating expectations, and raised its full-year revenue growth guidance to 15% to 25%. The company also lifted its year-end cash balance forecast to $81 billion to $83 billion while lowering its research and development expense outlook. Shares rose 0.41% in after-hours trading following the release.
Moderna Q3 EPS $0.38, raises full-year revenue growth guidance to 15%-25%
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
7m ago
Anthropic Sets Roadshow for IPO as Soon as Tuesday, Testing AI Pricing After Selloff
17m ago
26 A-share firms secure buyback, stake-increase loans in November
26m ago
AI server demand keeps PCB orders full; electronic cloth prices extend gains
38m ago
A-share buybacks top 33 billion yuan since October as CATL repurchases over 5 billion
53m ago
China Policy Package Supports A-Share Market as Institutions Build Counter-Cyclical Positions
56m ago
Skydance Expects Q4 Film Revenue Growth to Slow